Mode of action of Emcyt.
作者信息
Høisaeter P A
出版信息
Urology. 1984 Jun;23(6 Suppl):46-8. doi: 10.1016/s0090-4295(84)80097-7.
PMID:6375079
Abstract
摘要
相似文献
1
Mode of action of Emcyt.爱肌细胞（Emcyt）的作用方式。
Urology. 1984 Jun;23(6 Suppl):46-8. doi: 10.1016/s0090-4295(84)80097-7.
2
Estramustine phosphate (Estracyt): experimental and clinical studies in Europe.磷酸雌莫司汀（癌腺治）：欧洲的实验与临床研究
Semin Oncol. 1983 Sep;10(3 Suppl 3):27-33.
3
Estracyt--mode of action and clinical experience.雌莫司汀——作用机制与临床经验
Prog Clin Biol Res. 1987;243B:215-9.
4
Specific binding of estramustine to prostatic proteins.
Urology. 1984 Jun;23(6 Suppl):34-8. doi: 10.1016/s0090-4295(84)80095-3.
5
Intracellular effects of estramustine (Estracyt/Emcyt).
Prog Clin Biol Res. 1989;303:169-75.
6
Estramustine--current status, 1983.雌莫司汀——1983年的现状
Semin Oncol. 1983 Sep;10(3 Suppl 3):46-7.
7
Studies on the estramustine-binding protein in rat ventral prostate and in human prostate.
Scand J Urol Nephrol Suppl. 1980;55:133-4.
8
Inhibition by estramustine phosphate on estradiol and androgen binding in benign and malignant prostate in humans.磷酸雌莫司汀对人良性和恶性前列腺组织中雌二醇及雄激素结合的抑制作用。
Urology. 1976 Aug;8(2):118-21. doi: 10.1016/0090-4295(76)90335-6.
9
Estramustine phosphate: metabolic aspects related to its action in prostatic cancer.磷酸雌莫司汀：与它在前列腺癌中的作用相关的代谢方面。
J Urol. 1978 Feb;119(2):234-9.
10
[Pharmacology and metabolism of a new therapeutic drug for prostatic cancer "Estracyt"].一种新型前列腺癌治疗药物“雌莫司汀”的药理学与代谢
Gan To Kagaku Ryoho. 1984 Mar;11(3):537-44.
引用本文的文献
1
Evaluation of combined (177)Lu-DOTA-8-AOC-BBN (7-14)NH(2) GRP receptor-targeted radiotherapy and chemotherapy in PC-3 human prostate tumor cell xenografted SCID mice.联合（177）镥-多胺多羧基大环配体-8-氨基辛酰基环六肽-蛙皮素（7-14）氨基甘氨酰胺受体靶向放疗与化疗在人前列腺癌PC-3细胞异种移植SCID小鼠中的评估
Cancer Biother Radiopharm. 2006 Apr;21(2):155-66. doi: 10.1089/cbr.2006.21.155.
Zotero 插件